These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14650701)

  • 21. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.
    Lins RL; Daelemans R; Dratwa M; Verbeelen D; Sennesael J; Brisgand B; Lameire N
    Am J Med; 1989 Sep; 87(3C):41S-45S. PubMed ID: 2782326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rilmenidine: a clinical overview.
    Reid JL
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):106S-111S. PubMed ID: 10921529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and acceptability of rilmenidine in a population of 2 738 hypertensive diabetic patients].
    Kourilsky O; Meurin P
    Presse Med; 2002 Nov; 31(39 Pt 1):1864-8. PubMed ID: 12496718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
    Fiorentini C; Guillet C; Guazzi M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension.
    Nowak Ł; Adamczak M; Wiecek A
    Am J Hypertens; 2005 Nov; 18(11):1470-5. PubMed ID: 16280284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Essential arterial hypertension treated with rilmenidin : what dose for what patient?].
    Amah G
    Presse Med; 1999 Jan; 28(1):11-6. PubMed ID: 9951504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high-risk hypertensive patient and the potential for brain imidazoline receptor binding by rilmenidine.
    Laragh JH
    Am J Cardiol; 1994 Dec; 74(13):31A-35A. PubMed ID: 7998583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From alpha and beta to I1: an overview of sympathetic receptors involved in blood pressure control targets for drug treatment.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S5-10. PubMed ID: 8872294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment with rilmenidine 1 mg per day: time-lag to maximum response. A multicenter ambulatory study. Le Groupe Français d'étude Multicentrique d'Hyperium].
    Passeron J; Guillet C
    Presse Med; 1992 Dec; 21(43):2089-93. PubMed ID: 1297118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Imidazole receptor agonists--a new advance in the treatment of hypertension?].
    Spinar J; Vítovec J
    Vnitr Lek; 2000 Feb; 46(2):122-5. PubMed ID: 11048538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
    Trimarco B; Rosiello G; Sarno D; Lorino G; Rubattu S; DeLuca N; Volpe M
    Am J Cardiol; 1994 Dec; 74(13):36A-42A. PubMed ID: 7998584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are centrally acting imidazoline agents appropriate therapy for renovascular hypertension?
    Head GA; Burke SL
    Ann N Y Acad Sci; 2003 Dec; 1009():234-43. PubMed ID: 15028593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.